Division of Pharmacy and Optometry, Lydia Becker Institution of Immunology and Inflammation, Faculty of Biology Medicine and Health, University of Manchester, Manchester, United Kingdom.
Department of Microbiology, Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom.
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02012-20.
Diabetic foot ulcers are notoriously difficult to heal, with ulcers often becoming chronic, in many cases leading to amputation despite weeks or months of antibiotic therapy in addition to debridement and offloading. Alternative wound biofilm management options, such as topical rather than systemic delivery of antimicrobials, have been investigated by clinicians in order to improve treatment outcomes. Here, we collected blood and tissue from six subjects with diabetic foot infections, measured the concentrations of antibiotics in the samples after treatment, and compared the microbiota within the tissue before treatment and after 7 days of antibiotic therapy. We used an model of polymicrobial biofilm infection inoculated with isolates from the tissue we collected to simulate different methods of antibiotic administration by simulated systemic therapy or topical release from calcium sulfate beads. We saw no difference in biofilm bioburden in the models after simulated systemic therapy (representative of antibiotics used in the clinic), but we did see reductions in bioburden of between 5 and 8 logs in five of the six biofilms that we tested with topical release of antibiotics via calcium sulfate beads. Yeast is insensitive to antibiotics and was a component of the sixth biofilm. These data support further studies of the topical release of antibiotics from calcium sulfate beads in diabetic foot infections to combat the aggregate issues of infectious organisms taking the biofilm mode of growth, compromised immune involvement, and poor systemic delivery of antibiotics via the bloodstream to the site of infection in patients with diabetes.
糖尿病足溃疡的愈合极具挑战性,溃疡常常变得慢性,在许多情况下,尽管经过数周或数月的抗生素治疗、清创和减压,仍会导致截肢。为了改善治疗效果,临床医生研究了替代伤口生物膜管理的选择,例如局部而不是全身递送抗生素。在这里,我们从六位患有糖尿病足感染的患者中采集血液和组织样本,在治疗后测量样本中的抗生素浓度,并比较治疗前和治疗 7 天后组织内的微生物群。我们使用一种从我们收集的组织中分离出的多微生物生物膜感染模型,模拟不同的抗生素给药方法,包括模拟全身治疗的系统治疗或通过硫酸钙珠的局部释放。我们在模拟全身治疗(代表临床使用的抗生素)的模型中没有看到生物膜生物负荷的差异,但我们确实看到在六种生物膜中,有五种的生物负荷减少了 5 到 8 个对数级,这些生物膜通过硫酸钙珠局部释放抗生素进行了测试。酵母对抗生素不敏感,是第六种生物膜的一个组成部分。这些数据支持进一步研究硫酸钙珠从糖尿病足感染中局部释放抗生素,以应对感染生物采取生物膜生长模式、免疫受损和抗生素通过血流向感染部位的全身输送不佳等综合问题。